美國
US 12,702,650 B2
Methods and compositions for treating smith-magenis syndrome
US 12,702,650 B2 是美國專利商標局（USPTO）的核准專利，日期 2026-08-11。申請人：The Regents of the University of California。PDF 可在本頁下載，未登入每天最多 5 篇。
有人下載過這份 PDF 後，這裡會顯示首頁預覽。
- 申請人
- The Regents of the University of California
- 發明人
- Yimin Zou; John Scott; Sonal Thakar
- 公開日
- 2026-08-11
- 申請日
- 2021-12-22
- 文件種類
- B2 核准公告
- 也寫作
- US 12,702,650 B2 · US12702650 · 12702650
摘要
The present invention is based on the finding that subanesthetic doses of N-methyl-D-aspartate (NMDA) receptor antagonists alleviate social interaction deficits associated with behavioral disorders, such as Smith-Magenis Syndrome (SMS). The invention therefore provides methods and compositions for treating SMS. Also provided are methods of selecting NMDA receptor agonists useful in alleviating social interaction deficits associated with such behavioral disorders.
這裡只列摘要開頭，完整內容在 PDF 裡。
不用登入，每天可下載 5 篇（今天還剩 5 篇）。批次下載與 OA 引證整理需免費註冊。
專利局網站： 美國專利商標局（USPTO）